Lymphoma, Mantle-Cell - 25 Studies Found Completed : Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma : Lymphoma, Mantle-Cell : 2002-06-03 : Drug: Yttrium-ibritumomab (Zevalin) Completed : Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL) : Lymphoma, Mantle-Cell : 2010-10-13 : Drug: Combination of dexamethasone, ofatumumab and bendamustine Completed : An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma. : Lymphoma, Mantle-Cell : 2007-01-05 : Drug: PD-0332991 125 mg, oral, Days 1-21 of a 28-day cycle Completed : Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma : Lymphoma, Mantle-cell : 2014-06-19 : Drug: Ibrutinib Participants will receive ibrutinib capsules 560 milligram (mg) orally, once daily on a Completed : Immunochemotherapy With Rituximab-Bendamustine-Cytarabine (R-BAC) for Patients With Mantle Cell Lymphoma : Lymphoma, Mantle-Cell : 2009-10-07 : Drug: Rituximab, Bendamustine, Cytarabine Rituximab IV 375 Completed : Safety and Efficacy of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy. : Lymphoma, Mantle- Cell : 2008-06-19 : Drug: RAD001 Completed : Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment : Lymphoma, Mantle-Cell : 2015-01-14 Completed : A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma : Lymphoma, Mantle Cell : 2016-11-21 : Drug: Acalabrutinib in combination with bendamustine and rituximab Not yet recruiting : Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese Participants : Lymphoma, Mantle-Cell : 2017-02-10 Completed : Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma : Lymphoma, Mantle-Cell : 2009-10-08 : Biological: Tositumomab and Iodine I 131 Tositumomab followed by CHOP Patients will receive an infusion Next >>>
